Oral Administration of Type I Interferon Modulates the Course of Experimental Allergic Neuritis

References

• Isaacs A., Lindenmann J., Virus Interference I. The interferon. Proc. R. Soc. Lond. (Biol) 1957; 147: 258–261
   PubMed Web of Science ®Google Scholar
• Johnson H. M., Baron S. Evaluation of effects of interferon and interferon inducers on the immune response. Pharmac. Ther 1911; 1: 349–367
   Google Scholar
• Balkwill F. R. The regulatory role of interferons in the human immune response. Interferons: The impact in biology of medicine, Taylor‐Papadimitriou. Oxford Medical Publications. 1985; 61–80
   Google Scholar
• Ververken D., Carton H., Biliau A. Intrathecal administration of interferon in MS patients. Humoral immunity in neurological disease, D. Karcher, A. Lowenthal, A. D. Strosberg. Plenum, New York 1979; 625–627
   Google Scholar
• Fog T. Interferon treatment of multiple sclerosis patients: a pilot study. Search for a cause of multiple sclerosis and other chronic diseases of the CNS, A. Boese. Verlag Chemie, Weinheim 1980; 491–493
   Google Scholar
• Montezuma‐de‐Carvalho M. J. A treatment for the chronic disabilities of stable multiple sclerosis. Acta Medicotechnica 1983; 31: 155–160
   Google Scholar
• Panitch H. S., Francis G. S., Hooper C. J., Merigan T. C., Johnson K. P. Serial immunological studies in multiple sclerosis patients treated systemically with human interferon alpha. Ann. Neurol 1985; 18: 434–438
   Google Scholar
• Panitch H. S. Systemic alpha‐interferon in multiple sclerosis: Long term patient follow‐up. Arch. Neurol 1987; 44: 61–63
   Google Scholar
• Knobler R. L. Systemic interferon therapy of multiple sclerosis: the pros. Neurology 1988; 38: 58–61
   Google Scholar
• Kastrukoff L. F., Oger J. J., Hashimoto S. A., Sacks S. L., Li D. K., Palmer M. R., Koopmans R. A., Pethau A. J., Berkowitz J., Paty D. W. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 1990; 40: 479–486
   PubMed Web of Science ®Google Scholar
• IFNB Multiple Sclerosis Study Group. Interferon beta‐lb is effective in relapsing‐remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo‐controlled trial. Neurology 1993; 43: 655–661
   PubMed Web of Science ®Google Scholar
• Paty D. W., Li D. K. B. UBC MS/MRI Study Group and IFNB Multiple Sclerosis Study Group. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. 11. MRI analysis results of a multicenter, randomized, double blind, placebo‐controlled trial. Neurology 1993; 43: 662–667
   PubMed Web of Science ®Google Scholar
• Jacobs L., Cookfair D., Rudick R., Herndon R., Salazar A., Fisher J., Granger C., Simon J., Goodkin D., and the MS Collaborative Group. Results of a Phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis. Ann. Neural 1994; 36(2)259
   Web of Science ®Google Scholar
• Sabatelli M., Mignogna T., Lippi G., Milone M., Di Lazarro V., Tonali P. Interferon‐a may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J. Neurol. Neurosurg. Psych 1995; 58: 638–639
   PubMed Web of Science ®Google Scholar
• Leger J. M., Xavier M., Chastang C., Clavelou P., Louboutin J. P., Bouche P., Brouet J. C., and the IgM Associated Polyneuropathy Study Group. A randomized trial comparing alpha‐interferon and intravenous immunoglobulin in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 1996; 46: A280
   Google Scholar
• Abreu S. L. Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Comm 1982; 11: 1–7
   PubMed Web of Science ®Google Scholar
• Abreu S. L., Tondreau J., Levine D., Sowinskli R. Inhibition of passive localized experimental allergic encephalomyelitis by interferon. Int. Arch. Allergy Appl. Immunol 1983; 72: 30–33
   PubMedGoogle Scholar
• Schafer T. W., Lieberman M., Cohen M., Came P. Interferon administered orally: protection of neonatal mice from lethal virus challenge. Science 1972; 176: 1326–1327
   PubMed Web of Science ®Google Scholar
• Cummins J. M., Thompkins M. S., Olsen R. G., Tompkins W. A., Lewis M. G. Oral use of human alpha interferon in cats. J. Biol. Response Modifiers 1988; 7: 513–523
   PubMedGoogle Scholar
• Young A. S., Maritim A. C., Karuiki D. P., Stagg D. A., Wafula J. M., Mutugi J. J., Cummins J. M., Richards A. S., Burns C. Low‐dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle. J. Parasital 1990; 101: 201–209
   Google Scholar
• Stanton G., Hughes T., Heard H., Georgiades J., Whorton E. Modulation of a natural virus defense system by low concentrations of interferons at mucosal surfaces. J. In: Res 1990; 10(S‐1)S99
   Google Scholar
• Lecce J. G., Cummins J. M., Richards A. S. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon aipha. J. Mol. Biotherapy 1990; 2: 211–216
   Google Scholar
• Brod S. A., Burns D. H. Suppression of relapsing experimental allergic encephalomyelitis in SJL/J mouse by oral administration of type I interferons. Neurology 1994; 44: 1144–1148
   Google Scholar
• Brod S. A., Scott M., Burns D. K., Phillips J. T. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of Type Interferons. J. Int. Res 1995; 15: 115–122
   Google Scholar
• Norton W. T. Isolation of myelin from the nerve tissue. Methods Enzymol 1975; 31(part A)435
   Google Scholar
• Hahn A. F., Feasby T. E., Wilkie L., Lovgren D. P2‐peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol 1991; 82: 60–65
   Google Scholar
• Rostami A., Gregorian S. K., Brown M. J., Pleasure D. E. Induction of severeexperimental autoimmune neuritis with a synthetic peptide corresponding to the 53–78 amino acid sequence of the myelin P2 protein. J Neuroimmunol 1990; 30: 145–151
   Google Scholar
• Schmidt B., Stoll G., Van der Meide P., Jung S., Hartung H. P. Transient cellular expression of interferon‐gamma in myelin‐induced and T cell line‐mediated experimental autoimmune neuritis. Bruin 1992; 115: 1633–1646
   PubMedGoogle Scholar
• Brod S. A., Khan M., Kerman R. H., Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and prevents adoptive transfer in EAE. J. Neuroimmunol 1995; 58: 61–69
   Google Scholar
• Macdonald T. T. Immunosuppression caused by antigen feeding. 11. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur. J. Immunol 1983; 13: 138–142
   Google Scholar
• Mattingly J. A. Immunologic suppression after oral administration of antigen. Cell. Immunol 1984; 86: 45–52
   Google Scholar
• Santes L. M. B., Al‐Sabbagh A., Londono A., Weiner H. L. Oral tolerance to MBP induces TGF‐P secreting T cells in Peyer's patch. J. Immunol 1993; 150: 115A
   Google Scholar
• Aune T. M., Pierce C. W. Activation of a suppressor T cell pathway by interferon. Proc. Natl. Acad. Sci. USA 1982; 79: 3808–3812
   PubMedGoogle Scholar
• Schnapper H. W., Pierce C. W., Aune T. M. Identification and initial characterization of Con A and interferon‐induced human suppressor factor: Evidence for a human equivalent of murine soluble immune response suppressor (SIRS). J. Immmunol 1984; 132: 2429–2435
   Google Scholar
• Merrill J. E., Kono D. H., Clayton J., Ando D. G., Hinton D. R. Inflammatory leukocyes and cytokines in the peptide‐induced disease of experimental allergic encephalomyelitis in SJL and B10. PL mice. Prac. Natl. Acad. Sci. USA 1992; 89: 810–815
   Google Scholar
• Hartung H. P., Schafer B., Van der Meide P. H., Fierz W., Heininger K., Toyka K. V. The role of interferon‐gamma in the pathogenesis of experimental autoimmune disease of the nervous system. Ann. Neurol 1990; 27: 247–257
   PubMed Web of Science ®Google Scholar
• Tsai C. P., Pollard J. O., Armati P. J. Interferon‐γ inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression on Schwann cells in vitro. J. Neuroimmunol 1991; 31: 133–145
   PubMedGoogle Scholar
• Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokata T. Cytokines: Coordinators of immune and inflammtory responses. Annu. Rev. Biochem 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar